Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Maia Boscá

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Medicina Clinica|December 17, 2017
Crohn's diseaseMaría Pilar Ballester Ferré, Marta Maia Boscá-Watts, Miguel Mínguez Pérez
Revista Espanola De Enfermedades Digestivas|April 5, 2017
Coloduodenal and enterocutaneous fistula in twins with Crohn´s diseaseMaíia Pilar Ballester, David Martí, Marta Maia Boscá Watts, et al.
World Journal of Gastroenterology|August 29, 2006
Factors predicting poor prognosis in ischemic colitisRamón Añón, Marta Maia Boscá, Vicente Sanchiz, et al.
World Journal of Gastroenterology|December 6, 2008
Methotrexate induced sprue-like syndromeMarta Maia Boscá, Ramon Añón, Empar Mayordomo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 31, 2026
Decanoic acid in Crohn's disease-associated complications: Antifibrotic effect mediated by PPARγAndrea Cejudo-Garcés, Jalpa Patel, Ana Jarén, et al.
Digestive Diseases and Sciences|January 4, 2019
Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for RelapseMarisa Iborra, Julia Herreras, Marta Maia Boscá-Watts, et al.
Revista Espanola De Enfermedades Digestivas|January 9, 2025
Inflammatory bowel disease vs strongyloidiasisTeresa García Ballester, Sheila González Padilla, Marta Maia Boscá-Watts, et al.
Journal of Clinical Medicine|May 28, 2022
Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without AnaemiaJose María Huguet, Xavier Cortés, Marta Maia Boscá-Watts, et al.
Revista Espanola De Enfermedades Digestivas|December 5, 2015
IBD or strongyloidiasis?Marta Maia Boscá Watts, Andrea Marco Marqués, Ester Savall-Núñez, et al.
Biomedicines|September 23, 2022
Subcutaneous Infliximab [CT-P13], a True Biologic 2.0. Real Clinical Practice Multicentre StudyJose M Huguet, Victor García-Lorenzo, Lidia Martí, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Medicina Clinica|December 17, 2017
Crohn's diseaseMaría Pilar Ballester Ferré, Marta Maia Boscá-Watts, Miguel Mínguez Pérez
Revista Espanola De Enfermedades Digestivas|April 5, 2017
Coloduodenal and enterocutaneous fistula in twins with Crohn´s diseaseMaíia Pilar Ballester, David Martí, Marta Maia Boscá Watts, et al.
World Journal of Gastroenterology|August 29, 2006
Factors predicting poor prognosis in ischemic colitisRamón Añón, Marta Maia Boscá, Vicente Sanchiz, et al.
World Journal of Gastroenterology|December 6, 2008
Methotrexate induced sprue-like syndromeMarta Maia Boscá, Ramon Añón, Empar Mayordomo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 31, 2026
Decanoic acid in Crohn's disease-associated complications: Antifibrotic effect mediated by PPARγAndrea Cejudo-Garcés, Jalpa Patel, Ana Jarén, et al.
Digestive Diseases and Sciences|January 4, 2019
Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for RelapseMarisa Iborra, Julia Herreras, Marta Maia Boscá-Watts, et al.
Revista Espanola De Enfermedades Digestivas|January 9, 2025
Inflammatory bowel disease vs strongyloidiasisTeresa García Ballester, Sheila González Padilla, Marta Maia Boscá-Watts, et al.
Journal of Clinical Medicine|May 28, 2022
Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without AnaemiaJose María Huguet, Xavier Cortés, Marta Maia Boscá-Watts, et al.
Revista Espanola De Enfermedades Digestivas|December 5, 2015
IBD or strongyloidiasis?Marta Maia Boscá Watts, Andrea Marco Marqués, Ester Savall-Núñez, et al.
Biomedicines|September 23, 2022
Subcutaneous Infliximab [CT-P13], a True Biologic 2.0. Real Clinical Practice Multicentre StudyJose M Huguet, Victor García-Lorenzo, Lidia Martí, et al.
Pageof 2